Business Context and Reporting Period
This Form 8-K Current Report was filed by Alnylam Pharmaceuticals, Inc. on March 25, 2011, regarding events occurring on March 21, 2011. The filing addresses the departure of a principal officer and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on a specific executive compensation event.
- Severance Payment: $250,397 (gross), equivalent to 12 months of base salary.
- Health Benefits: Full COBRA premium coverage until March 31, 2012, or until new coverage eligibility.
- Consulting Fee: Terms for a 12-month consulting agreement were established, though specific fee amounts are not detailed in this text.
- Equity: Continued vesting of unvested stock options during the consulting term.
Material Changes
The primary material change is the resignation of Patricia L. Allen as Vice President, Finance and Treasurer, effective February 28, 2011, with a separation date of March 21, 2011. Michael P. Mason is identified as the new Vice President, Finance and Treasurer, signing the report on behalf of the company.
Outlook, Risks, and Unusual Items
Management Commentary: The company entered into a Separation Agreement and a subsequent Consulting Agreement with Ms. Allen to ensure a transition of duties regarding general accounting, operating budgets, public company financial reporting, and treasury activities.
Unusual Items: The filing details a structured exit package including a one-year consulting arrangement and accelerated equity vesting, which are standard but material compensatory arrangements for executive departures.
Investor Verification Checklist
- Verify the appointment and background of Michael P. Mason as the new Vice President, Finance and Treasurer.
- Confirm the total financial impact of the severance and consulting agreement on the company's current quarter expenses.
- Review the specific terms of the Consulting Agreement to understand the scope of Ms. Allen's continued involvement.
- Check for any subsequent filings regarding the replacement of Ms. Allen's specific treasury or reporting responsibilities if the consulting arrangement ends early.